← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Aehr swung from profit to loss as revenue fell and cash burn widened.
The read at a glance✓ Audited against SEC data
- Growth — Revenue -10.9% to $59.0MWatch
- Profitability — Net income -111.8% to -$3.9MWatch
- Cash quality — FCF -1330.6% to -$12.4MWatch
- Margins — Gross margin -856 bpsWatch
- Capital — Capex +566.5% to $5.0MWatch
- Insiders — 0 buys / 40 sellsWatch
- Accounting — Z grey; EQ greyNote
Business
Aehr Test Systems supplies test and burn-in systems for semiconductor devices in wafer-level, singulated die, and packaged-part form, with products used in silicon carbide, gallium nitride, sensors, memory, processors, photonics, and AI-related devices.
Where the revenue comes from
Fiscal 2026, as AEHR TEST SYSTEMS reports it. History and quarterly detail are in the app.
- Systems$28.7M
- Contactors$14.9M
- Services$6.4M
Leadership changes
From AEHR TEST SYSTEMS's own filings, the day they're filed.
- Kenneth B. Spink · Chief Financial Officer · departureeff. 2023-08-31
- David S. Hendrickson · Chief Technology Officer · departureeff. 2023-05-31
- David S. Hendrickson · Chief Technology Officer · departure
Latest filings
- 10-K · Annual report2026-07-27
- 8-K · Company announcement2026-07-14
- 8-K · Company announcement2026-04-20
- 8-K · Company announcement2026-04-08
- 10-Q · Quarterly report2026-04-08
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about AEHR TEST SYSTEMS, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.